Metro International Biotech, LLC

Works in Genetic & rare · Infectious disease · Metabolic & endocrine · Neurology · Renal & urogenital · Respiratory · Women's health

Metro International Biotech, LLC is a clinical trial sponsor. It has 2 active clinical trials with 64 planned participants, across 7 therapeutic areas. Since 2021 it has completed 3 trials and stopped 0 early.

Trial track record · since 2021

2Active trials64 planned participants
3Completed1 with results posted
0Stopped earlyterminated, withdrawn or suspended

Pipeline · 2 active trials

StageTrialStatus

Questions about Metro International Biotech, LLC

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-02-19.

Approve Suite is not affiliated with Metro International Biotech, LLC.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.